Case Disclosed

The Risks of Trump's Proposal to Speed Up Drug Approvals

February 20, 2017
By Mark Doré

President Trump has signaled—often and recently—that he believes drug approval moves too slowly. Meeting with drug manufacturers at the White House on Jan. 31, Trump promised quick yes-or-no approval decisions on new drugs (and stressed the need for lower prices and U.S.-based manufacturing).

Read more

Health Canada’s Draft Guidance for Implementing Vanessa’s Law Limits Transparency

January 7, 2017
By Kathleen Choi

Canada’s public health department, Health Canada, is preparing to release its final guidance on the section of Vanessa’s Law designed to promote the transparency of information around pharmaceutical drugs.

Read more

New Disclosures Reflect NSLs’ Substantive First Amendment Flaws

December 19, 2016
By Hannah Bloch-Wehba

This year has seen a remarkable string of disclosures about national security letters (NSLs), the secret demands the FBI sends to financial and communications service providers compelling the disclosure of customer information and transactional data.

Read more

MFIA’s Lethal Injection Access Litigation: Statutory and Constitutional Strategies

November 23, 2016
By Allison Douglis

This post’s focus is on lethal injection access litigation that the Clinic has been carrying out in Missouri on behalf of five national and state news organizations.

Read more